Newsroom

Industry News

14 Dec

Drone Aviation Appoints Bruce R.C. Hardy as New Vice President of Sales

JACKSONVILLE, FL–(Marketwired – December 14, 2016) – Drone Aviation Holding Corp. (DRNE) (“Drone Aviation” the “Company” or “DAC”), a leading provider of tethered drones and lighter-than-air aerostats, today announced the appointment of Bruce R.C. Hardy as its new Vice President of Sales. Mr. Hardy is a former U.S. Navy...

Read more

14 Dec

Cellectar Biosciences Announces USPTO Grants Patent Allowances for Radiotherapeutic PDCs for A Variety of Solid Tumor Types

MADISON, Wis., Dec. 14, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (CLRB) (the “company”), an oncology-focused clinical stage biotechnology company, today announced that the United States Patent and Trademark Office (“USPTO”) has issued patent allowances covering method of use for radiotherapy with the company’s lead compound, CLR 131, as...

Read more

13 Dec

Actinium Pharmaceuticals Announces Submission of EU Orphan Designation Application for Actimab-A

NEW YORK, Dec. 13, 2016 (GLOBE NEWSWIRE) — Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that the Company has submitted an application with the European Medicines Agency (EMA) seeking Orphan Designation for...

Read more

13 Dec

Moleculin Presents Preclinical Data of Novel Inhibitor of Glycolysis at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

HOUSTON, TX–(Marketwired – December 13, 2016) – Moleculin Biotech, Inc., (MBRX)(“Moleculin” or the “Company”), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, many of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, today...

Read more

12 Dec

Actinium to Sponsor Upcoming Blood & Marrow Transplant Information Network Webinar Focused on Stem Cell Transplants for Patients with AML

NEW YORK, Dec. 12, 2016 (GLOBE NEWSWIRE) — Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that the Company is sponsoring a patient focused webinar that is being conducted on Wednesday, December 14,...

Read more

12 Dec

Nemus Bioscience Reports Prodrug of Tetrahydrocannabinol (THC) Receives Intellectual Property Protection in the European Union (E.U.) and Australia Following Patents issued in the United States and Japan

COSTA MESA, CA / ACCESSWIRE / December 12, 2016 / NEMUS Bioscience, Inc.(NMUS) announced that a patent has been granted covering the company’s proprietary prodrug of THC, THC-valine-hemisuccinate (THCVHS), in Australia, and that another patent will be allowed covering THCVHS in the E.U., pending company identification of E.U. member...

Read more

12 Dec

Cellectar Biosciences Announces USPTO Grants Patent for Paclitaxel PDC; Provides Additional Patent Protection for Select Solid Tumors Through 2035

MADISON, Wis., Dec. 12, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (CLRB) (the “company”), an oncology-focused clinical stage biotechnology company, today announced that the United States Patent and Trademark Office (“USPTO”) has granted patent number 9,480,754 covering the method of use for CLR 1603 to treat breast, lung, colorectal...

Read more

9 Dec

Monster Digital, Inc. Exhibits New Products at Hudson Group Show

SIMI VALLEY, CA–(Marketwired – Dec 9, 2016) – Monster Digital, Inc. ( NASDAQ : MSDI ) (“Monster Digital” or the “Company”), which develops, markets and distributes Monster Digital® branded products for use in high-performance consumer electronics, mobile products and computing applications, today announced exhibition of its new Virtual Reality...

Read more

Page 20 of 222« First...10...1819202122...304050...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address